Skip to main content
Erschienen in: Tumor Biology 4/2016

23.10.2015 | Original Article

RRP12 is a crucial nucleolar protein that regulates p53 activity in osteosarcoma cells

verfasst von: Young Joon Choi, Hye Won Lee, Yun Sun Lee, Da Mi Shim, Sung Wook Seo

Erschienen in: Tumor Biology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

RRP12 (ribosomal RNA processing 12 homolog), a nucleolar protein, plays important roles in cell cycle progression and the response to deoxyribonucleic acid (DNA) damage in yeast cells. However, its role has not been investigated in mammalian cells that possess p53, which has close functional association to nucleolus. We explored the role of RRP12 in nucleolar stress condition using an osteosarcoma cell line, U2OS. To induce DNA damage and nucleolar disruption, two cytotoxic drugs, doxorubicin and actinomycin D were used. Cytotoxic stress resulted nucleolar disruption induced cell cycle arrest and apoptosis in U2OS cells. However, RRP12 overexpression promoted resistance to cytotoxic stress. In contrast, RRP12 silencing enhanced susceptibility to cytotoxic stress. During drug treatment, p53 activity and cell death were suppressed by RRP12 overexpression but promoted by RRP12 silencing. This study demonstrated that RRP12 was crucial for cell survival during cytotoxic stress via the repression of p53 stability. Thus, targeting RRP12 may enhance chemotherapeutic effect in cancers.
Literatur
1.
Zurück zum Zitat Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502:333–9.CrossRefPubMedPubMedCentral Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502:333–9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 2003;22:6068–77.CrossRefPubMedPubMedCentral Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 2003;22:6068–77.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, Steen H, et al. Directed proteomic analysis of the human nucleolus. Curr Biol CB. 2002;12:1–11.CrossRefPubMed Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, Steen H, et al. Directed proteomic analysis of the human nucleolus. Curr Biol CB. 2002;12:1–11.CrossRefPubMed
7.
Zurück zum Zitat Oeffinger M, Dlakic M, Tollervey D. A pre-ribosome-associated heat-repeat protein is required for export of both ribosomal subunits. Genes Dev. 2004;18:196–209.CrossRefPubMedPubMedCentral Oeffinger M, Dlakic M, Tollervey D. A pre-ribosome-associated heat-repeat protein is required for export of both ribosomal subunits. Genes Dev. 2004;18:196–209.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Vanrobays E, Leplus A, Osheim YN, Beyer AL, Wacheul L, Lafontaine DL. Tor regulates the subcellular distribution of dim2, a kh domain protein required for cotranscriptional ribosome assembly and pre-40s ribosome export. RNA. 2008;14:2061–73.CrossRefPubMedPubMedCentral Vanrobays E, Leplus A, Osheim YN, Beyer AL, Wacheul L, Lafontaine DL. Tor regulates the subcellular distribution of dim2, a kh domain protein required for cotranscriptional ribosome assembly and pre-40s ribosome export. RNA. 2008;14:2061–73.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Dosil M. Ribosome synthesis-unrelated functions of the preribosomal factor rrp12 in cell cycle progression and the DNA damage response. Mol Cell Biol. 2011;31:2422–38.CrossRefPubMedPubMedCentral Dosil M. Ribosome synthesis-unrelated functions of the preribosomal factor rrp12 in cell cycle progression and the DNA damage response. Mol Cell Biol. 2011;31:2422–38.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kalita K, Makonchuk D, Gomes C, Zheng JJ, Hetman M. Inhibition of nucleolar transcription as a trigger for neuronal apoptosis. J Neurochem. 2008;105:2286–99.CrossRefPubMedPubMedCentral Kalita K, Makonchuk D, Gomes C, Zheng JJ, Hetman M. Inhibition of nucleolar transcription as a trigger for neuronal apoptosis. J Neurochem. 2008;105:2286–99.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Avitabile D, Bailey B, Cottage CT, Sundararaman B, Joyo A, McGregor M, et al. Nucleolar stress is an early response to myocardial damage involving nucleolar proteins nucleostemin and nucleophosmin. Proc Natl Acad Sci USA. 2011;108:6145–50.CrossRefPubMedPubMedCentral Avitabile D, Bailey B, Cottage CT, Sundararaman B, Joyo A, McGregor M, et al. Nucleolar stress is an early response to myocardial damage involving nucleolar proteins nucleostemin and nucleophosmin. Proc Natl Acad Sci USA. 2011;108:6145–50.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Huang M, Itahana K, Zhang Y, Mitchell BS. Depletion of guanine nucleotides leads to the mdm2-dependent proteasomal degradation of nucleostemin. Cancer Res. 2009;69:3004–12.CrossRefPubMedPubMedCentral Huang M, Itahana K, Zhang Y, Mitchell BS. Depletion of guanine nucleotides leads to the mdm2-dependent proteasomal degradation of nucleostemin. Cancer Res. 2009;69:3004–12.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Derenzini M, Montanaro L, Trere D. What the nucleolus says to a tumour pathologist. Histopathology. 2009;54:753–62.CrossRefPubMed Derenzini M, Montanaro L, Trere D. What the nucleolus says to a tumour pathologist. Histopathology. 2009;54:753–62.CrossRefPubMed
15.
Zurück zum Zitat Trere D, Borzio M, Morabito A, Borzio F, Roncalli M, Derenzini M. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to hbv infection. Hepatology. 2003;37:72–8.CrossRefPubMed Trere D, Borzio M, Morabito A, Borzio F, Roncalli M, Derenzini M. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to hbv infection. Hepatology. 2003;37:72–8.CrossRefPubMed
16.
Zurück zum Zitat Dai MS, Lu H. Inhibition of mdm2-mediated p53 ubiquitination and degradation by ribosomal protein l5. J Biol Chem. 2004;279:44475–82.CrossRefPubMed Dai MS, Lu H. Inhibition of mdm2-mediated p53 ubiquitination and degradation by ribosomal protein l5. J Biol Chem. 2004;279:44475–82.CrossRefPubMed
17.
Zurück zum Zitat Zhang Q, Xiao H, Chai SC, Hoang QQ, Lu H. Hydrophilic residues are crucial for ribosomal protein l11 (rpl11) interaction with zinc finger domain of mdm2 and p53 protein activation. J Biol Chem. 2011;286:38264–74.CrossRefPubMedPubMedCentral Zhang Q, Xiao H, Chai SC, Hoang QQ, Lu H. Hydrophilic residues are crucial for ribosomal protein l11 (rpl11) interaction with zinc finger domain of mdm2 and p53 protein activation. J Biol Chem. 2011;286:38264–74.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Sasaki M, Kawahara K, Nishio M, Mimori K, Kogo R, Hamada K, et al. Regulation of the mdm2-p53 pathway and tumor growth by pict1 via nucleolar rpl11. Nat Med. 2011;17:944–51.CrossRefPubMedPubMedCentral Sasaki M, Kawahara K, Nishio M, Mimori K, Kogo R, Hamada K, et al. Regulation of the mdm2-p53 pathway and tumor growth by pict1 via nucleolar rpl11. Nat Med. 2011;17:944–51.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, et al. Ribosomal protein l11 negatively regulates oncoprotein mdm2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol. 2003;23:8902–12.CrossRefPubMedPubMedCentral Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, et al. Ribosomal protein l11 negatively regulates oncoprotein mdm2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol. 2003;23:8902–12.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal protein l23 activates p53 by inhibiting mdm2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol. 2004;24:7654–68.CrossRefPubMedPubMedCentral Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal protein l23 activates p53 by inhibiting mdm2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol. 2004;24:7654–68.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zhang Y, Shi Y, Li X, Du W, Luo G, Gou Y, et al. Inhibition of the p53-mdm2 interaction by adenovirus delivery of ribosomal protein l23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. J Gene Med. 2010;12:147–56.CrossRefPubMed Zhang Y, Shi Y, Li X, Du W, Luo G, Gou Y, et al. Inhibition of the p53-mdm2 interaction by adenovirus delivery of ribosomal protein l23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. J Gene Med. 2010;12:147–56.CrossRefPubMed
22.
Zurück zum Zitat Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, et al. Ribosomal protein s7 as a novel modulator of p53-mdm2 interaction: binding to mdm2, stabilization of p53 protein, and activation of p53 function. Oncogene. 2007;26:5029–37.CrossRefPubMed Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, et al. Ribosomal protein s7 as a novel modulator of p53-mdm2 interaction: binding to mdm2, stabilization of p53 protein, and activation of p53 function. Oncogene. 2007;26:5029–37.CrossRefPubMed
Metadaten
Titel
RRP12 is a crucial nucleolar protein that regulates p53 activity in osteosarcoma cells
verfasst von
Young Joon Choi
Hye Won Lee
Yun Sun Lee
Da Mi Shim
Sung Wook Seo
Publikationsdatum
23.10.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4062-2

Weitere Artikel der Ausgabe 4/2016

Tumor Biology 4/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.